Interferon-lnduced vitiligo in a patient with chronic viral hepatitis c infection

Dermatology

Volumn 193, Issue 1, 1996, Pages 65-66

  Simsek, H ^a   Savas, C ^a   Akkiz, H ^a   Telatar, H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Chronic Hepatitis C; Interferons; Vitiligo

Indexed keywords

ALPHA2 INTERFERON;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; DEPIGMENTATION; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; MALE; MELANOCYTE; PRIORITY JOURNAL; VITILIGO;

ADULT; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HEPATITIS C; HUMANS; INTERFERONS; MALE; VITILIGO;

EID: 0030054546     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246208     Document Type: Article

References (11)

1. Ortonne JP, Bose SK: Vitiligo: Where do we stand? Pigment Cell Res 1993:6:61 72.
2. Sitnsck II: Interferon-alpha treatment of hemodialysis patients with chronic viral hepatitis C and its impact on kidney transplantation. Nephrol Dial Transplant, in press.
3. Primo J, Hinojosu J, Moles JR. Fernandez J. Martinez J, Miralles A. Otte A: Development of thyroid dysfunction after alpha-interferon treatment of chronic hepatitis C. Am J Gastroenterol 1993:88:1976-1977.
4. Garcia-Lora E. Tercedor J. Massare E. Lopez-Nevot MA. Skiljo M. Garcia-Mellado V: Interferon-induced psoriasis in a patient with chronic hepatitis C. Dermatology 1993:187: 280.
5. Harris J. Bines S. Das Gupta T: Therapy of disseminated metastatic melanoma with recombinant alpha 2b-interferon and piroxicam: Clinical results with a report of an unusual response-associated feature (vitiligo), and unusual toxicity (diffuse pulmonary interstitial fibrosis). Med Pediatr Oncol 1994:22:103-106.
6. Bernstein D. Reddy KR. Jeffers L. Schiff E: Canities and vitiligo complicating interferon therapy for hepatitis C. Am J Gastroenterol 1995;90:1176-1177.
7. Schallreuter KU. Lemke R. Brandt O. Schwartz R. Westhoven M. Montz R. Berger J: Vitiligo and other diseases: Coexistence or true association? Dermatology 1994:188:269-275.
8. Naughton GK. Eisinger M, Bystryn JC: Antibodies to normal human melanocytes in vitiligo. J Exp Med 1983:158:246-251.
9. Lorini R, Orecchia G. Marti net ti M, Dugoujon JM, Cuccia M: Autoimmunity in vitiligo: relationship with IILA. Gm and Km polymorphisms. Autoimmunity 1992:1:255-260.
10. Abdel-Naser MB. Kruger-Krasagakes S. Kra-sagakis K. Gollnick H. Orfanos CE: Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Pigment Cell Res 1994:7:1-8.
11. Wolkenstein P. Chosidow O, Guillaume JC. Wechsler J, Avil MF. Revuz J: Vitiligo-like lesions in melanoma treated with interleukin-2: 4 cases. Ann Dermatol Vcncrcol 1992:119: 907-909